After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin alfa ...
The FDA has approved Pfizer and Merck KGaA’s immunotherapy Bavencio (avelumab) as a first line maintenance therapy in bladder cancer, setting up a rivalry with alternatives from Roche and AstraZeneca.
Woman's World on MSN
4 pelvic floor exercises for incontinence that stop bladder leaks fast
A belly laugh with your best friend. A sneeze that catches you off guard. A quick jog to catch the bus. These everyday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results